<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1155  Imidocarb powder for injection.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. The product is a sterile powder containing  imidocarb dipropionate. Each milliliter of constituted solution contains  100 milligrams (mg) of imidocarb base.</p><p class="depth1"><em>(b)</em> Sponsor. See No. 000061 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Special considerations. Imidocarb dipropionate is sold only  under permit issued by the Director of the National Program Planning  Staff, Veterinary   Services, Animal and Plant Health Inspection Service, U.S. Department of  Agriculture, to licensed or full-time State, Federal, or military  veterinarians.</p><p class="depth1"><em>(d)</em> Conditions of use in horses and zebras--</p><p class="depth2"><em>(1)</em> Amount. For Babesia  caballi infections, administer 2 mg of imidocarb base per kilogram of  body weight by intramuscular injection in the neck region, repeating  dosage once after 24 hours. For Babesia equi infections, administer 4 mg  of imidocarb base per kilogram of body weight by intramuscular injection  in the neck region, repeating dosage four times at 72-hour intervals.</p><p class="depth2"><em>(2)</em> Indications for use. For the treatment of babesiosis  (piroplasmosis) caused by Babesia caballi and Babesia equi.</p><p class="depth2"><em>(3)</em> Limitations. Do not use in horses intended for human  consumption. Federal law restricts this drug to use by or on the order  of a licensed veterinarian.  [79 FR 16190, Mar. 25, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
